C.H. Robinson to acquire RXO in two-step merger for $17.25 cash plus 0.0856 CHR shares per RXO share

C.H. Robinson Worldwide entered into a definitive merger agreement to acquire RXO, with the RXO board unanimously approving the transaction. Each RXO shareholder will receive either (i) $17.25 cash plus 0.0856 shares of C.H. Robinson Common Stock, (ii) $30.25 cash, or (iii) 0.1992 C.H. Robinson shares; the transaction is expected to close in the first half of 2027. This eliminates RXO's public equity and marks a significant change of control event for both companies with clear valuation and capital structure implications.

C.H. Robinson is buying RXO. RXO shareholders will get a mix of cash and C.H. Robinson stock, with the deal expected to close in early 2027. RXO will stop trading as a separate company.